Geode Capital Management’s CAS Medical Systems CASM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-109,396
Closed -$265K – 4285
2019
Q1
$265K Buy
109,396
+79,511
+266% +$171K ﹤0.01% 3654
2018
Q4
$47K Hold
29,885
– – ﹤0.01% 4000
2018
Q3
$68K Buy
29,885
+12,117
+68% +$25.8K ﹤0.01% 3994
2018
Q2
$34K Buy
+17,768
New +$26.5K ﹤0.01% 4004

Geode Capital Management's CASM Position: Q2 2019 in Review

Geode Capital Management sold out of CAS Medical Systems (CASM) in Q2 2019, closing a stake of 109,396 shares — an estimated $265K sold.

Geode Capital Management first reported a position in CASM in Q2 2018 and held it in 4 quarters. The position peaked at $265K in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.

  • Geode Capital Management reported no remaining CAS Medical Systems position as of Q2 2019 after selling out during the quarter.
  • Geode Capital Management sold 109,396 CAS Medical Systems shares in Q2 2019, an estimated $265K.
  • Geode Capital Management first reported a position in CAS Medical Systems in Q2 2018 and held it in 4 quarters.
  • Geode Capital Management's CAS Medical Systems position peaked at $265K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held CAS Medical Systems as of Q2 2019.

Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.